NYSEAMERICAN:NBY NovaBay Pharmaceuticals Q2 2023 Earnings Report $0.60 +0.00 (+0.50%) As of 03:53 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. ProfileEarnings History NovaBay Pharmaceuticals EPS ResultsActual EPS-$1.27Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ANovaBay Pharmaceuticals Revenue ResultsActual Revenue$4.61 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ANovaBay Pharmaceuticals Announcement DetailsQuarterQ2 2023Date8/10/2023TimeN/AConference Call DateThursday, August 10, 2023Conference Call Time4:30PM ETUpcoming EarningsNovaBay Pharmaceuticals' Q2 2025 earnings is scheduled for Tuesday, August 12, 2025Conference Call ResourcesConference Call AudioConference Call TranscriptQuarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by NovaBay Pharmaceuticals Q2 2023 Earnings Call TranscriptProvided by QuartrAugust 10, 2023 ShareLink copied to clipboard.Key Takeaways The transcript only contains closing remarks and does not include any financial results or commentary. No performance metrics or operational updates were discussed during the call. There were no forward-looking statements or guidance provided to investors. AI Generated. May Contain Errors.Conference Call Audio Live Call not available Earnings Conference CallNovaBay Pharmaceuticals Q2 202300:00 / 00:00Speed:1x1.25x1.5x2xThere are 1 speakers on the call. Operator00:00:00Have a nice day. The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.Read morePowered by Earnings DocumentsQuarterly report(10-Q) NovaBay Pharmaceuticals Earnings HeadlinesNovaBay Pharmaceuticals (NBY) Projected to Post Quarterly Earnings on TuesdayAugust 11 at 2:46 AM | americanbankingnews.comNovaBay Pharmaceuticals, Inc. (NBY) - Yahoo FinanceJune 26, 2025 | finance.yahoo.comElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.August 12 at 2:00 AM | Brownstone Research (Ad)NovaBay extends CEO's contract through 2025January 22, 2025 | msn.comNovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLCOctober 29, 2024 | finance.yahoo.comNovaBay Pharmaceuticals receives unsolicited offer from Refresh AcquisitionsOctober 29, 2024 | msn.comSee More NovaBay Pharmaceuticals Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like NovaBay Pharmaceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NovaBay Pharmaceuticals and other key companies, straight to your email. Email Address About NovaBay PharmaceuticalsNovaBay Pharmaceuticals (NYSEAMERICAN:NBY) develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health. The company also provides wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. It sells its products through the company's web stores, third-party online retailers and distribution partners. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.View NovaBay Pharmaceuticals ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles CrowdStrike Faces Valuation Test Before Key Earnings ReportPost-Earnings, How Does D-Wave Stack Up Against Quantum Rivals?Why SoundHound AI's Earnings Show the Stock Can Move HigherAirbnb Beats Earnings, But the Growth Story Is Losing AltitudeDutch Bros Just Flipped the Script With a Massive Earnings BeatIs Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?Constellation Energy’s Earnings Beat Signals a New Era Upcoming Earnings Cisco Systems (8/13/2025)Alibaba Group (8/13/2025)Applied Materials (8/14/2025)NetEase (8/14/2025)Deere & Company (8/14/2025)NU (8/14/2025)Petroleo Brasileiro S.A.- Petrobras (8/14/2025)Palo Alto Networks (8/18/2025)Home Depot (8/19/2025)Medtronic (8/19/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
There are 1 speakers on the call. Operator00:00:00Have a nice day. The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.Read morePowered by